Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination

GLIA

Volumn 62, Issue 5, 2014, Pages 680-691

  Hussien, Yassir ^a   Cavener, Douglas R ^b   Popko, Brian ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

EAE; ER stress; Multiple sclerosis; Myelin; Oligodendrocytes

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; INITIATION FACTOR 2ALPHA; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PANCREATIC ENDOPLASMIC RETICULUM KINASE; PERTUSSIS TOXIN; PHOSPHOTRANSFERASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; PERK KINASE; PROTEIN KINASE R;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM STRESS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GENE INACTIVATION; HEART LEFT VENTRICLE; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NERVE FIBER; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING; WHITE MATTER; ANIMAL; C57BL MOUSE; DEFICIENCY; DEMYELINATING DISEASE; GENE DELETION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DEMYELINATING DISEASES; EIF-2 KINASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE DELETION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; OLIGODENDROGLIA; SIGNAL TRANSDUCTION;

EID: 84896319455     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22634     Document Type: Article

References (52)

1. Araki E, Oyadomari S, Mori M. 2003. Endoplasmic reticulum stress and diabetes mellitus. Intern Med 42:7-14.
2. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55:458-468.
3. Bauer J, Bradl M, Klein M, Leisser M, Deckwerth TL, Wekerle H, Lassmann H. 2002. Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: Gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. J Neuropathol Exp Neurol 61:12-22.
4. Bobrovnikova-Marjon E, Hatzivassiliou G, Grigoriadou C, Romero M, Cavener DR, Thompson CB, Diehl JA. 2008. PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc Natl Acad Sci USA 105:16314-16319.
5. Cunnea P, Mhaille AN, McQuaid S, Farrell M, McMahon J, FitzGerald U. 2011. Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Mult Scler 17:808-818.
6. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. 1997. Cell death and birth in multiple sclerosis brain. J Neurol Sci 149:1-11.
7. Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O. 2004. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 62:1509-1517.
8. Friedman AD. 1996. GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D cl3 myeloid cells. Cancer Res 56:3250-3256.
9. Frohman EM, Racke MK, Raine CS. 2006. Multiple sclerosis-The plaque and its pathogenesis. N Engl J Med 354:942-955.
10. Gao Y, Sartori DJ, Li C, Yu Q-C, Kushner JA, Simon MC, Diehl JA. 2012. PERK Is required in the adult pancreas and is essential for maintenance of glucose homeostasis. Mol Cell Biol 32:5129-5139.
11. Hagemeyer N, Goebbels S, Papiol S, Kästner A, Hofer S, Begemann M, Gerwig UC, Boretius S, Wieser GL, Ronnenberg A, Gurvich A, Heckers SH, Frahm J, Nave KA, Ehrenreich H. 2012. A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med 4:528-539.
12. Harding HP, Calfon M, Urano F, Novoa I, Ron D. 2002. Transcritional and translational control in the mammalian unfolded protein response. Ann Rev Cell Dev Biol 18:575-599.
13. Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, Ron D. 2001. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. Mol Cell 7:1153-1163.
14. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. 2000. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 5:897-904.
15. Harding HP, Zhang Y, Ron D. 1999. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397:271-274.
16. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, Ron D. 2003. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11:619-633.
17. Herz J, Zipp F, Siffrin V. 2010. Neurodegeneration in autoimmune CNS inflammation. Exp Neurol 225:9-17.
18. Hisahara S, Araki T, Sugiyama F, Yagami Ki, Suzuki M, Abe K, Yamamura K, Miyazaki J, Momoi T, Saruta T, Bernard CC, Okano H, Miura M. 2000. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J 19:341-348.
19. Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C. 2001. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36:220-234.
20. Kuerten S, Lehmann PV. 2011. The immune pathogenesis of experimental autoimmune encephalomyelitis: Lessons learned for multiple sclerosis? J Interferon Cytokine Res 31:907-916.
21. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave K-A. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
22. Leegwater PA, Vermeulen G, Könst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS. 2001. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 29:383-388.
23. Li Y, Iida K, O'Neil J, Zhang P, Li S, Frank A, Gabai A, Zambito F, Liang SH, Rosen CJ, Cavener DR., 2003. PERK eIF2α kinase regulates neonatal growth by controlling the expression of circulating insulin-like growth factor-I derived from the liver. Endocrinology 144:3505-3513.
24. Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD, Popko B. 2007. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest 117:448-456.
25. Lin W, Harding HP, Ron D, Popko B. 2005. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-γ. J Cell Biol 169:603-612.
26. Lin W, Kemper A, Dupree JL, Harding HP, Ron D, Popko B. 2006. Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129:1306-1318.
27. Lin W, Kunkler PE, Harding HP, Ron D, Kraig RP, Popko B. 2008. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am J Pathol 173:1508-1517.
28. Lin W, Lin Y, Li J, Fenstermaker AG, Way SW, Clayton B, Jamison S, Harding HP, Ron D, Popko B. 2013. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci 33:5980-5991.
29. Lin W, Popko B. 2009. Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 12:379-385.
30. Lindholm D, Wootz H, Korhonen L. 2006. ER stress and neurodegenerative diseases. Cell Death Differ 13:385-392.
31. Madhavarao CN, Moffett JR, Moore RA, Viola RE, Namboodiri MA, Jacobowitz DM. 2004. Immunohistochemical localization of aspartoacylase in the rat central nervous system. J Comp Neurol 472:318-329.
32. Matute C, Perez-Cerda F. 2005. Multiple sclerosis: Novel perspectives on newly forming lesions. Trends Neurosci 28:173-175.
33. Mc Guire C, Volckaert T, Wolke U, Sze M, de Rycke R, Waisman A, Prinz M, Beyaert R, Pasparakis M, van Loo G. 2010. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination. J Immunol 185:7646-7653.
34. McMahon JM, McQuaid S, Reynolds R, FitzGerald UF. 2012. Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis. Mult Scler 18:1437-1447.
35. Mhaille AN, McQuaid S, Windebank A, Cunnea P, McMahon J, Samali A, FitzGerald U. 2008. Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J Neuropathol Exp Neurol 67:200-211.
36. Ni Fhlathartaigh M, McMahon J, Reynolds R, Connolly D, Higgins E, Counihan T, Fitzgerald U. 2013. Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination. Acta Neuropathol Commun 1:37.
37. Novoa I, Zhang Y, Zeng H, Jungreis R, Harding HP, Ron D. 2003. Stress-induced gene expression requires programmed recovery from translational repression. EMBO J 22:1180-1187.
38. Oyadomari S, Araki E, Mori M. 2002. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 7:335-345.
39. Oyadomari S, Mori M. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11:381-389.
40. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, Lassmann H. 1994. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322.
41. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
42. Pfrieger FW, Slezak M. 2012. Genetic approaches to study glial cells in the rodent brain. Glia 60:681-701.
43. Ron D, Hampton RY. 2004. Membrane biogenesis and the unfolded protein response. J Cell Biol 167:23-25.
44. Saadat L, Dupree JL, Kilkus J, Han X, Traka M, Proia RL, Dawson G, Popko B. 2010. Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice. Glia 58:391-398.
45. Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. 2010. Multiple sclerosis-Candidate mechanisms underlying CNS atrophy. Trends Neurosci 33:202-210.
46. Southwood CM, Garbern J, Jiang W, Gow A. 2002. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36:585-596.
47. Stromnes IM, Goverman JM. 2006. Passive induction of experimental allergic encephalomyelitis. Nat Protoc 1:1952-1960.
48. Traka M, Arasi K, Avila RL, Podojil JR, Christakos A, Miller SD, Soliven B, Popko B. 2010. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 133:3017-3029.
49. Trapp BD, Nave KA. 2008. Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269.
50. Wei J, Sheng X, Feng D, McGrath B, Cavener DR. 2008. PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. J Cell Physiol 217:693-707.
51. Zhang P, McGrath B, Li Sa, Frank A, Zambito F, Reinert J, Gannon M, Ma K, McNaughton K, Cavener DR. 2002. The PERK eukaryotic initiation factor 2α kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol 22:3864-3874.
52. Zhang W, Feng D, Li Y, Iida K, McGrath B, Cavener DR. 2006. PERK EIF2AK3 control of pancreatic β cell differentiation and proliferation is required for postnatal glucose homeostasis. Cell Metab 4:491-497.